NCT05013554 Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors Status TERMINATED Phase PHASE1
NCT04717375 Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT04203524 Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis Status TERMINATED Phase NA
NCT04142567 Role of the Pharmacist in Detection of Drug Interactions Before Antitumor Treatment Initiation Status COMPLETED Phase N/A
NCT04138823 A Study to Test Different Doses of BI 891065 Alone and in Combination With BI 754091 in Asian Patients With Different Types of Advanced Cancer (Solid Tumours) Status COMPLETED Phase PHASE1
NCT03637764 Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies Status TERMINATED Phase PHASE1/PHASE2
NCT03547037 A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers Status COMPLETED Phase PHASE1
NCT03251924 A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT03099161 Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062) Status TERMINATED Phase PHASE1
NCT02955446 Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies Status NO_LONGER_AVAILABLE Phase N/A
NCT02875327 Linkage of Medicaid Enrollment Information to Surveillance, Epidemiology and End Results Data Status COMPLETED Phase N/A
NCT02851706 Natural History of and Specimen Banking for People With Tumors of the Central Nervous System Status COMPLETED Phase N/A
NCT02828449 Assesment of the Implementation of a Therapeutic Educational Intervention Affecting Adherence to Oral Chemotherapy Status UNKNOWN Phase NA
NCT02759666 A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02747342 A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer Status COMPLETED Phase PHASE1
NCT02746185 Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban Status COMPLETED Phase PHASE3